Genetic control of susceptibility to carcinogen-induced colorectal cancer in mice: The Ccs3 and Ccs5 loci regulate different aspects of tumorigenesis

Cell Cycle

Volumn 10, Issue 11, 2011, Pages 1739-1749

  Meunier, Charles ^a   Kwan, Tony ^a   Turbide, Claire ^b   Beauchemin, Nicole ^a,b   Gros, Philippe ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Azoxymethane; Ccs3; Ccs5; Colon cancer; Gene mapping; Genetics; Susceptibility

Indexed keywords

AZOXYMETHANE; CARCINOGEN; COLON CANCER SUSCEPTIBILITY LOCUS 3; COLON CANCER SUSCEPTIBILITY LOCUS 5; GLUTATHIONE TRANSFERASE A4; PHOSPHOLIPID SCRAMBLASE 2; PHOSPHOLIPID SCRAMBLASE 4; PROTEIN ADAMTS 7; PROTEIN COL 12 ALPHA 1; PROTEIN CTSH; PROTEIN TTK; SCRAMBLASE; SERINE; THREONINE; TUMOR MARKER; UNCLASSIFIED DRUG;

ALLELE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME 3; CHROMOSOME 9; COLITIS; COLORECTAL CANCER; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GENETIC REGULATION; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; MEMBRANE LEAFLET; NONHUMAN; PHENOTYPE; PROMOTER REGION; RECESSIVE GENE; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 79957879589     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.11.15817     Document Type: Review

References (69)

1. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2010. Toronto: Canadian Cancer Society 2010.
2. American Cancer Society. Cancer Facts & Figures 2010. Atlanta: American Cancer Society 2010.
3. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 2003; 3:695-701. (Pubitemid 37328824)
4. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108-13. (Pubitemid 350134889)
5. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
6. Demant P. Cancer susceptibility in the mouse: Genetics, biology and implications for human cancer. Nat Rev Genet 2003; 4:721-34. (Pubitemid 37046139)
7. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008; 40:1426-35.
8. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4:769-80.
9. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361:2066-78.
10. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007; 39:984-8. (Pubitemid 47185182)
11. Jaeger E, Webb E, Howarth K, Carvajal-Carmona L, Rowan A, Broderick P, et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 2008; 40:26-8.
12. Tenesa A, Farrington SM, Prendergast JGD, Porteous ME, Walker M, Haq N, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008; 40:631-7. (Pubitemid 351601219)
13. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman A, et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008; 40:623-30.
14. Zanke BW, Greenwood CMT, Rangrej J, Kustra R, Tenesa A, Farrington SM, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007; 39:989-94. (Pubitemid 47185183)
15. Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, Howarth K, et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 2010; 42:973-7.
16. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009; 10:353-8.
17. Quigley D, Balmain A. Systems genetics analysis of cancer susceptibility: From mouse models to humans. Nat Rev Genet 2009; 10:651-7.
18. Dragani TA. 10 years of mouse cancer modifier loci: Human relevance. Cancer Res 2003; 63:3011-8. (Pubitemid 36735842)
19. Suzui M, Okuno M, Tanaka T, Nakagama H, Moriwaki H. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. Cancer letters 2002; 183:31-41. (Pubitemid 34607349)
20. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004; 95:475-80. (Pubitemid 38832695)
21. Nambiar PR, Girnun G, Lillo NA, Guda K, Whiteley HE, Rosenberg DW. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. International journal of oncology 2003; 22:145-50.
22. Jacoby RF, Hohman C, Marshall DJ, Frick TJ, Schlack S, Broda M, et al. Genetic analysis of colon cancer susceptibility in mice. Genomics 1994; 22:381-7. (Pubitemid 24258881)
23. Fijneman RJ, Demant P. A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4. Cancer Res 1995; 55:3179-82.
24. Angel JM, Popova N, Lanko N, Turusov VS, DiGiovanni J. A locus that influences susceptibility to 1,2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3. Mol Carcinog 2000; 27:47-54. (Pubitemid 30090002)
25. Ruivenkamp CAL, van Wezel T, Zanon C, Stassen APM, Vlcek C, Csikós T, et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 2002; 31:295-300.
26. Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, Meijer G, et al. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 2003; 22:3472-4. (Pubitemid 36713745)
27. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1:55-67. (Pubitemid 33741881)
28. Nilbert M, Kristoffersson U, Ericsson M, Johannsson O, Rambech E, Mangell P. Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72. BMC Med Genet 2008; 9:101.
29. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75:631-9. (Pubitemid 23346362)
30. Silverman KA, Koratkar R, Siracusa LD, Buchberg AM. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res 2002; 12:88-97. (Pubitemid 34065592)
31. Min/+ Mom1S mice. Proc Natl Acad Sci USA 2005; 102:2868-73.
32. Min on chromosomes 18 and 11. AACR Meeting Abstracts 2006.
33. Oikarinen SI, Cleveland AG, Cork KM, Bynoté KK, Rafter JJ, Gustafsson JA, et al. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis. Carcinogenesis 2009; 30:1591-6.
34. Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA, et al. The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene, 2000:3182-92. (Pubitemid 30455930)
35. Kwong LN, Shedlovsky A, Biehl BS, Clipson L, Pasch CA, Dove WF. Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18. Genetics, 2007:1237-44. (Pubitemid 46961118)
36. Crist RC, Roth JJ, Lisanti MP, Siracusa LD, Buchberg AM. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis. Cell Cycle 2011; 10.
37. Min-induced intestinal neoplasia. Cell 1995; 81:957-66.
38. Tomlinson IP, Neale K, Talbot IC, Spigelman AD, Williams CB, Phillips RK, et al. A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. Journal of medical genetics 1996; 33:268-73.
39. Herzog CR, Wang Y, You M. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene 1995; 11:1811-5.
40. Hong KH, Bonventre JC, O'Leary E, Bonventre JV, Lander ES. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc Natl Acad Sci USA 2001; 98:3935-9.
41. Baran AA, Silverman KA, Zeskand J, Koratkar R, Palmer A, McCullen K, et al. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res 2007; 17:566-76. (Pubitemid 46715506)
42. Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, Gros P. Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 2003; 35:357-62. (Pubitemid 37486919)
43. Meunier C, Cai J, Fortin A, Kwan T, Marquis JF, Turbide C, et al. Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3. Oncogene 2010; 29:647-61.
44. Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, Hunter K. An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome 2000; 11:883-9.
45. Nagase H, Mao JH, Balmain A. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc Natl Acad Sci USA 1999; 96:15032-7. (Pubitemid 30019760)
46. Angel JM, Beltrán L, Minda K, Rupp T, DiGiovanni J. Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol Carcinog 1997; 20:162-7. (Pubitemid 27508879)
47. Festing MF, Yang A, Malkinson AM. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet Res 1994; 64:99-106. (Pubitemid 24357660)
48. Lemon WJ, Bernert H, Sun H, Wang Y, You M. Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet 2002; 39:644-55. (Pubitemid 35001717)
49. Bouma G, Kaushiva A, Strober W. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 2002; 123:554-65. (Pubitemid 34827199)
50. Kozaiwa K, Sugawara K, Smith MF, Carl V, Yamschikov V, Belyea B, et al. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology 2003; 125:477-90. (Pubitemid 36929430)
51. Borm MEA, He J, Kelsall B, Peña AS, Strober W, Bouma G. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models. Gastroenterology 2005; 128:74-85. (Pubitemid 40039960)
52. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, et al. Ulcerative colitis and adenocarcinoma of the colon in G alphai2-deficient mice. Nat Genet 1995; 10:143-50.
53. Stone EL, Ismail MN, Lee SH, Luu Y, Ramirez K, Haslam SM, et al. Glycosyltransferase function in core 2-type protein O glycosylation. Mol Cell Biol 2009; 29:3770-82.
54. Park IC, Lee SH, Whang DY, Hong WS, Choi SS, Shin HS, et al. Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines. Anticancer Res 1997; 17:4619-22. (Pubitemid 28081755)
55. Zong WX, Edelstein LC, Chen C, Bash J, Gélinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NFkappaB that blocks TNFalpha-induced apoptosis. Genes Dev 1999; 13:382-7. (Pubitemid 29108753)
56. Starr TK, Allaei R, Silverstein KAT, Staggs RA, Sarver AL, Bergemann TL, et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009; 323:1747-50.
57. Ruiz-Herrera A, Robinson TJ. Evolutionary plasticity and cancer breakpoints in human chromosome 3. Bioessays 2008; 30:1126-37.
58. Darai-Ramqvist E, Sandlund A, Müller S, Klein G, Imreh S, Kost-Alimova M. Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions. Genome Res 2008; 18:370-9. (Pubitemid 351347080)
59. Mitelman F, Johansson B, Mertens FE. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer 2010.
60. Tang J, Le S, Sun L, Yan X, Zhang M, Macleod J, et al. Copy number abnormalities in sporadic canine colorectal cancers. Genome Res 2010; 20:341-50.
61. Schoch C, Haase D, Haferlach T, Freund M, Link H, Lengfelder E, et al. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17) (q22;q21): A report on 50 patients. Br J Haematol 1996; 94:493-500. (Pubitemid 26284073)
62. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40:616-22. (Pubitemid 351601203)
63. Hansen HM, Xiao Y, Rice T, Bracci PM, Wrensch MR, Sison JD, et al. Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans. Hum Mol Genet 2010; 19:3652-61.
64. Franke A, Mcgovern DPB, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genet 2010; 42:1118-25.
65. Haritunians T, Taylor KD, Targan SR, Dubinsky M, Ippoliti A, Kwon S, et al. Genetic predictors of medically refractory ulcerative colitis. Inflammatory Bowel Diseases 2010; 16:1830-40.
66. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, Rouleau GA, et al. Recombinant congenic strains derived from A/J and C57BL/6J: A tool for genetic dissection of complex traits. Genomics 2001; 74:21-35. (Pubitemid 32500263)
67. Haley CS, Knott SA. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 1992; 69:315-24.
68. Lander ES, Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989; 121:185-99.
69. Broman KW, Wu H, Sen S, Churchill GA. R/ qtl: QTL mapping in experimental crosses. Bioinformatics 2003; 19:889-90.